Intratumoural chemotherapy of lung cancer for diagnosis and treatment of draining lymph node metastasis

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 3, 2010, Pages 287-295

  Celikoglu, Firuz ^a   Celikoglu, Seyhan I ^a   Goldberg, Eugene P ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Endobronchial intratumoural chemotherapy; Intratumoural cytotoxic drug injection; Lung cancer; Lymphatic drainage to lymph nodes; Sentinel lymph node detection

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; MITOXANTRONE; TRACER;

BRONCHOSCOPY; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; HUMAN; INTRAOPERATIVE PERIOD; ISOTOPE LABELING; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; MICROMETASTASIS; NONHUMAN; PATHOGENESIS; PREOPERATIVE EVALUATION; REVIEW; SENTINEL LYMPH NODE;

ANTINEOPLASTIC AGENTS; BRONCHOSCOPES; CARCINOMA, NON-SMALL-CELL LUNG; EARLY DETECTION OF CANCER; HUMANS; INJECTIONS, INTRALESIONAL; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM;

EID: 77950295281     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.03.0001     Document Type: Review

References (61)

1. Wingo, PA, et al. Cancer statistics, 1995. CA Cancer J Clin 1995 45 : 8 30.
2. Landis, SH, et al. Cancer statistics, 1999. CA Cancer J Clin 1999 49 : 8 31.
3. Seely, JM, et al. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 1993 186 : 129 132.
4. Naruke, T, et al. The importance of surgery to non small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 1960 39 : 555 572.
5. Liptay, MJ. Sentinel lymph node mapping in lung cancer. Ann Surg Oncol 2004 11 : 271S 274S.
6. Mountain, CF. Dresler, CM. Regional lymph node classification for lung cancer staging. Chest 1997 111 : 1718 1723.
7. Hanahan, D. Weinberg, RA. The hallmarks of cancer. Cell 2000 100 : 57 70.
8. Kell, MR, et al. Biological behavior and clinical implications of micrometastases. Br J Surg 2000 87 : 1629 1639.
9. Nomori, H, et al. Omission of mediastinal lymph node dissection in lung cancer: its technique and diagnostic procedures. Ann Thorac Cardiovasc Surg 2006 12 : 83 88.
10. Graham, AN, et al. Systemic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999 117 : 246 251.
11. Izbicki, JR, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 1998 227 : 138 144.
12. Wu, YL, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002 36 : 1 6.
13. Spiro, SG. Porter, JC. Lung cancer - where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002 166 : 1166 1196.
14. Sandler, AB, et al. Phase III trial gemcitabine plus cisplatin versus cisplatin alone with patients with locally advanced or metastatic non-small lung cancer. J Clin Oncol 2000 18 : 122 130.
15. Gatzemeir, U, et al. Phase III comparative study of high dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small lung cancer. J Clin Oncol 2001 19 : 2108 2109.
16. Trovo, MG, et al. Combined radiotherapy and chemotherapy vs. radiotherapy alone in locally advanced bronchogenic carcinoma: a randomized study. Cancer 1990 65 : 400 404.
17. Trovo, MG, et al. Radiotherapy (RT) versus RT enhanced by cisplatin (CDPG) in stage III non-small cell lung cancer (NSCLC): randomized cooperative study. Lung Cancer 1991 7 158.
18. Shaake-Koning, C, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992 326 : 524 530.
19. Shaake-Konig, C, et al. Radiosensitization by cytotoxic drugs. The EORTC experience by radiotherapy and lung cancer cooperative groups. Lung Cancer 1994 10 S263 S270.
20. Pass, HI, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992 53 : 992 998.
21. Yoneda, S, et al. A comparative trial on induction chemoradiotherapy followed by surgery (CRS) or immediate surgery (IS) for stage III non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1995 14 : A1128.
22. Depierre, A, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small cell lung cancer. J Clin Oncol 2002 20 : 247 253.
23. Roth, JA, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994 86 : 673 680.
24. Rosell, R, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994 330 : 153 158.
25. Noppen, M. Amjadi, K. Do pulmonologists need to tighten up their sphincter tone? Do pulmonologists need more guts?. Respiration 2006 73 : 18 19.
26. Goldberg, EP, et al. Intratumoral cancer chemotherapy and immunotherapy: opportunities for non-systemic preoperative drug delivery. J Pharm Pharmacol 2002 54 : 159 180.
27. Celikoglu, SI, et al. Direct injection of anticancer drugs into endobronchial tumors for major airway obstruction. Postgrad Med J 1997 73 : 159 162.
28. Celikoglu, F. Celikoglu, SI. Intratumoral chemotherapy with 5-fluorouracil for palliation of bronchial cancer in patients with severe airway obstruction. J Pharm Pharmacol 2003 55 : 1441 1448.
29. Celikoglu, F, et al. Bronchoscopic intratumoral chemotherapy of lung cancer. Lung Cancer 2008 61 : 1 12.
30. Celikoglu, F, et al. Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer. Lung Cancer 2006 51 : 225 236.
31. Celikoglu, F, et al. Techniques for intratumoral chemotherapy of lung cancer by bronchoscopic drug delivery. Cancer Ther 2008 6 : 545 552.
32. Hayata, Y, et al. Immunotherapy for lung cancer cases using BCG or BCG cell-wall skeleton: intratumoral injections. Gann Monogr Cancer Res 1978 21 : 151 160.
33. Wagai, F, et al. The direct injection of several anti-cancer drugs into the primary lung cancer through a fiberoptic bronchoscope. Jpn J Thorac Dis 1982 20 : 170.
34. Liu, M, et al. Local chemotherapy by fibrobronchoscopy for advanced broncogenic carcinoma. Chin J Tuberc Respir Dis 2000 23 : 550 551.
35. Seymour, CW, et al. Transbronchial needle injection: a systemic review of a new diagnostic and therapeutic paradigm. Respiration 2006 73 : 78 89.
36. Shayan, R, et al. Lymphatic vessels in cancer metastasis: bridging gaps. Carcinogenesis 2006 27 : 1729 1738.
37. Alitalo, K, et al. Lymphangiogenesis in development and human disease. Nature 2005 438 : 946 953.
38. Pepper, MS. Lymphangiogenesis and tumor metastasis: myth or reality?. Clin Cancer Res 2001 7 : 462 468.
39. Oliver, G. Harvey, N. A stepwise model of the development of lymphatic vasculature. Ann NY Acad Sci 2002 979 : 159 165.
40. Lardinois, D, et al. Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer. Eur J Cardiothorac Surg 2003 23 : 824 827.
41. McHale NG. Lymph circulation and lymph propulsion. In : Proceedings of the First International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy. New York : Springer Publishing Co, 2005 : 4.
42. Fidler, IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003 3 : 453 458.
43. Asamura, H. Suzuki, K. Kondo, H. Where is the boundary between N1 and N2 station in lung cancer?. Ann Thorac Surg 2000 70 : 1839 1845.
44. Wu, J, et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 2001 71 : 1772 1778.
45. Pieterman, RM, et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med 2000 343 : 254 261.
46. Nomori, H, et al. The size of metastatic foci and lymph node staging yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 2004 127 : 1087 1092.
47. Kernstine, KH, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer?. Ann Thorac Surg 2002 73 : 394 402.
48. Morton, DL, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 1992 127 : 392 399.
49. Tiffet, O, et al. Detection of lymph nodes metastases in malignant melanoma after identification of the sentinel lymph node with preoperative lymphoscintigraphy and intraopereative radio-isotopic detection. Ann Chir 2000 125 : 32 39.
50. Tiffet, O, et al. Sentinel lymph node detection in primary melanoma with preoperative dynamic lymphoscintigraphy and intraoperative gamma probe guidance. Br J Surg 2004 91 : 886 892.
51. Dadras, SS, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2004 162 : 1951 1960.
52. Yokoyama, Y, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 2003 88 : 237 244.
53. Liptay, MJ, et al. Intraoperative sentinel lymph node mapping in non-small cell lung cancer improves detection of micrometastases. J Clin Oncol 2002 20 : 1984 1988.
54. Schmith, FE. Rozan, MH. Sentinel nodal assessment in patients with carcinoma of the lung. Ann Thorac Surg 2002 74 : 870 874.
55. Sugi, K, et al. Effect of radioisotope sentinel lymph node mapping in patients with T1N0M0 lung cancer. J Thorac Cardiovasc Surg 2003 126 : 568 573.
56. Tiffet, O, et al. Feasibility of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radio isotopic and blue dye techniques. Chest 2005 127 : 443 448.
57. Liptay, MJ, et al. Intraoperative radioisotope sentinel lymph node mapping in non-small-cell lung cancer. Ann Thorac Surg 2000 70 : 384 390.
58. Levine, S. Cherson, J. Morphologic effects of mitoxantrone and a related antracendione of lymphatic tissue. Int J Immunopharmacol 1986 8 : 999 1007.
59. Baitchev, G, et al. Perioperative locoregional application of mitoxantrone in patients with early breast carcinoma. J Chemother 2001 13 : 440 443.
60. Celikoglu, SI, et al. Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small-cell lung cancer with polypoid growth causing erroneous impression of advanced disease. Lung Cancer 2006 54 : 339 346.
61. Xie, Y, et al. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv 2009 6 : 785 792.